Adherium Grows Subscription Revenue 12.5%

The remote asthma monitoring company reported a fifth consecutive quarterly record for recurring subscription revenue in its September quarter.

Updated on Nov. 1, 2026 in Asthma

Adherium Grows Subscription Revenue 12.5%

Live Poll

Do you think healthcare access for chronic conditions is getting better or worse?

Adherium's remote patient monitoring recurring subscription revenue rose 12.5% to $539,000 in the September quarter, marking its fifth straight quarterly record. The company also reported customer receipts of $544,000, up 33% from the preceding quarter.

Why it matters

The results show continued uptake of Adherium's Hailie asthma monitoring platform among clinics and patients. The company is also preparing to extend its US operating model into value-based care contracts with insurers and health systems.

The figures come from Adherium's company-reported September quarter results, which show $539,000 in recurring subscription revenue, up 12.5% quarter over quarter and 381% above the September 2025 quarter. Cumulative totals stand at 6,392 Hailie devices shipped and 4,732 activated, and how the pending Medicare rule will affect these figures remains unresolved.

The players

Adherium

Adherium is a company that provides remote patient monitoring technology for asthma, including its Hailie platform.

Florida Lung, Asthma & Sleep Specialists

Florida Lung, Asthma & Sleep Specialists is a Central Florida clinical practice that partnered with Adherium to extend the Hailie platform into the region.

The details

Billable revenue is recognized when patients activate devices rather than when equipment ships, and more than 90% of Allergy Partners clinic locations now participate in the program. A partnership with Florida Lung, Asthma & Sleep Specialists following quarter-end extended the Hailie platform into Central Florida.

July: John Perry became interim chief executive officer.
September quarter: Subscription revenue rose 12.5% to $539,000, a fifth consecutive record.
October: Brad Wilson joined as chief financial officer.
November: A final Medicare rule is expected and could differ from the July proposal.

Health Landscape

The results extend the Hailie platform's adoption as clinics add devices and patients activate them, a model that depends on how reimbursement rules for remote monitoring are finalized. Adherium's shift toward value-based care contracts with insurers and health systems places its growth within the broader move to pay for outcomes in chronic disease management.

For asthma patients, remote monitoring devices like Hailie track use and can support earlier outreach from clinical staff, which may change how routine follow-up happens. Whether these services are covered and at what cost to patients will depend on the final Medicare rules still pending.

The takeaway

Remote monitoring programs are increasingly tied to how clinics get paid, so patients may see these tools more often as reimbursement models shift. Following the final Medicare rule will show how coverage for devices like Hailie is set.

What happens next

A final Medicare rule is expected in November and could differ from the July proposal. Adherium also plans a 20-person feasibility study with Lurie Children's Hospital.